200 related articles for article (PubMed ID: 28939229)
21. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
Hattangadi JA; Rombi B; Yock TI; Broussard G; Friedmann AM; Huang M; Chen YL; Lu HM; Kooy H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1015-22. PubMed ID: 22138463
[TBL] [Abstract][Full Text] [Related]
22. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
23. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors.
Kahalley LS; Ris MD; Grosshans DR; Okcu MF; Paulino AC; Chintagumpala M; Moore BD; Guffey D; Minard CG; Stancel HH; Mahajan A
J Clin Oncol; 2016 Apr; 34(10):1043-9. PubMed ID: 26811522
[TBL] [Abstract][Full Text] [Related]
24. Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011.
Wang EH; Mougalian SS; Soulos PR; Smith BD; Haffty BG; Gross CP; Yu JB
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):303-11. PubMed ID: 25442334
[TBL] [Abstract][Full Text] [Related]
25. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
Sato M; Gunther JR; Mahajan A; Jo E; Paulino AC; Adesina AM; Jones JY; Ketonen LM; Su JM; Okcu MF; Khatua S; Dauser RC; Whitehead WE; Weinberg J; Chintagumpala MM
Cancer; 2017 Jul; 123(13):2570-2578. PubMed ID: 28267208
[TBL] [Abstract][Full Text] [Related]
26. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
[TBL] [Abstract][Full Text] [Related]
27. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
28. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
Shaverdian N; Verruttipong D; Wang PC; Kishan AU; Demanes DJ; McCloskey S; Kupelian P; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):516-525. PubMed ID: 28126301
[TBL] [Abstract][Full Text] [Related]
29. Comparison of mean radiation dose and dosimetric distribution to tooth-bearing regions of the mandible associated with proton beam radiation therapy and intensity-modulated radiation therapy for ipsilateral head and neck tumor.
Owosho AA; Yom SK; Han Z; Sine K; Lee NY; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):566-571. PubMed ID: 27765327
[TBL] [Abstract][Full Text] [Related]
30. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
31. Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
Cushman TR; Venigalla S; Brooks ED; Lin C; Verma V
Anticancer Res; 2018 May; 38(5):2923-2927. PubMed ID: 29715118
[TBL] [Abstract][Full Text] [Related]
32. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
[TBL] [Abstract][Full Text] [Related]
33. Clinical utilization of radiation therapy in Korea, 2016.
Kim E; Jang WI; Kim MS; Paik EK; Kim HJ; Yoo HJ; Yang K; Cho CK
J Radiat Res; 2020 Mar; 61(2):249-256. PubMed ID: 31913473
[TBL] [Abstract][Full Text] [Related]
34. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
[TBL] [Abstract][Full Text] [Related]
35. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM
Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819
[TBL] [Abstract][Full Text] [Related]
36. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
37. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
White EC; Murphy JD; Chang DT; Koong AC
Am J Clin Oncol; 2015 Dec; 38(6):564-9. PubMed ID: 24401668
[TBL] [Abstract][Full Text] [Related]
38. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
[TBL] [Abstract][Full Text] [Related]
39. A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy.
Rim CH; Lee J; Kim WC; Yang D; Yoon WS; Koom WS; Kim CY
J Korean Med Sci; 2018 Feb; 33(9):e67. PubMed ID: 29441739
[TBL] [Abstract][Full Text] [Related]
40. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.
Amini A; Jones BL; Yeh N; Rusthoven CG; Armstrong H; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1052-63. PubMed ID: 26581142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
